Literature DB >> 26508631

Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.

Wei Hu1, Aakanksha Jain1, Yajing Gao1, Igor M Dozmorov1, Rajakumar Mandraju1, Edward K Wakeland1, Chandrashekhar Pasare2.   

Abstract

Recognition of pathogen-associated molecular patterns by Toll-like receptors (TLRs) on dendritic cells (DCs) leads to DC maturation, a process involving up-regulation of MHC and costimulatory molecules and secretion of proinflammatory cytokines. All TLRs except TLR3 achieve these outcomes by using the signaling adaptor myeloid differentiation factor 88. TLR4 and TLR3 can both use the Toll-IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF)-dependent signaling pathway leading to IFN regulatory factor 3 (IRF3) activation and induction of IFN-β and -α4. The TRIF signaling pathway, downstream of both of these TLRs, also leads to DC maturation, and it has been proposed that the type I IFNs act in cis to induce DC maturation and subsequent effects on adaptive immunity. The present study was designed to understand the molecular mechanisms of TRIF-mediated DC maturation. We have discovered that TLR4-TRIF-induced DC maturation was independent of both IRF3 and type I IFNs. In contrast, TLR3-mediated DC maturation was completely dependent on type I IFN feedback. We found that differential activation of mitogen-activated protein kinases by the TLR4- and TLR3-TRIF axes determined the type I IFN dependency for DC maturation. In addition, we found that the adjuvanticity of LPS to induce T-cell activation is completely independent of type I IFNs. The important distinction between the TRIF-mediated signaling pathways of TLR4 and TLR3 discovered here could have a major impact in the design of future adjuvants that target this pathway.

Entities:  

Keywords:  LPS | Poly I:C | MAVS; MAP kinases; NF-κB activation

Mesh:

Substances:

Year:  2015        PMID: 26508631      PMCID: PMC4653191          DOI: 10.1073/pnas.1510760112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  An associative analysis of gene expression array data.

Authors:  Igor Dozmorov; Michael Centola
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Regulation of phagosome maturation by signals from toll-like receptors.

Authors:  J Magarian Blander; Ruslan Medzhitov
Journal:  Science       Date:  2004-05-14       Impact factor: 47.728

Review 3.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

4.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

5.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

6.  Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.

Authors:  Enrico Proietti; Laura Bracci; Simona Puzelli; Tiziana Di Pucchio; Paola Sestili; Enrico De Vincenzi; Massimo Venditti; Imerio Capone; Isabelle Seif; Edward De Maeyer; David Tough; Isabella Donatelli; Filippo Belardelli
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

7.  Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection.

Authors:  Kenya Honda; Shinya Sakaguchi; Chigusa Nakajima; Ai Watanabe; Hideyuki Yanai; Misako Matsumoto; Toshiaki Ohteki; Tsuneyasu Kaisho; Akinori Takaoka; Shizuo Akira; Tsukasa Seya; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.

Authors:  William S Bowen; Laurie A Minns; David A Johnson; Thomas C Mitchell; Melinda M Hutton; Jay T Evans
Journal:  Sci Signal       Date:  2012-02-14       Impact factor: 8.192

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.

Authors:  Kasper Hoebe; Edith M Janssen; Sung O Kim; Lena Alexopoulou; Richard A Flavell; Jiahuai Han; Bruce Beutler
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

View more
  32 in total

1.  Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Authors:  Paurvi Shinde; Wenhai Liu; Antoine Ménoret; Andrew D Luster; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2017-04-21       Impact factor: 4.962

2.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

3.  Dissociation of TRIF bias and adjuvanticity.

Authors:  Katharina Richard; Darren J Perkins; Erin M Harberts; Yang Song; Archana Gopalakrishnan; Kari Ann Shirey; Wendy Lai; Alexandra Vlk; Anup Mahurkar; Shreeram Nallar; Lynn D Hawkins; Robert K Ernst; Stefanie N Vogel
Journal:  Vaccine       Date:  2020-05-07       Impact factor: 3.641

4.  Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.

Authors:  Madhu V Singh; Michael Z Cicha; Sarah Nunez; David K Meyerholz; Mark W Chapleau; François M Abboud
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-22       Impact factor: 4.733

5.  Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Mol Neurobiol       Date:  2019-05-16       Impact factor: 5.590

6.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

7.  Neutrophil extracellular trap fragments stimulate innate immune responses that prevent lung transplant tolerance.

Authors:  Davide Scozzi; Xingan Wang; Fuyi Liao; Zhiyi Liu; Jihong Zhu; Katy Pugh; Mohsen Ibrahim; Hsi-Min Hsiao; Mark J Miller; Guo Yizhan; Thalachallour Mohanakumar; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman
Journal:  Am J Transplant       Date:  2018-12-13       Impact factor: 8.086

8.  Effector memory CD4+ T cells induce damaging innate inflammation and autoimmune pathology by engaging CD40 and TNFR on myeloid cells.

Authors:  Margaret M McDaniel; Amanpreet Singh Chawla; Aakanksha Jain; Hannah E Meibers; Irene Saha; Yajing Gao; Viral Jain; Krishna Roskin; Sing Sing Way; Chandrashekhar Pasare
Journal:  Sci Immunol       Date:  2022-01-21

9.  PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.

Authors:  Meropi Aravantinou; Ines Frank; Magnus Hallor; Rachel Singer; Hugo Tharinger; Jessica Kenney; Agegnehu Gettie; Brooke Grasperge; James Blanchard; Andres Salazar; Michael Piatak; Jeffrey D Lifson; Melissa Robbiani; Nina Derby
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

10.  TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.

Authors:  Elke Gülden; Chen Chao; Ningwen Tai; James A Pearson; Jian Peng; Monika Majewska-Szczepanik; Zhiguang Zhou; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2018-06-28       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.